Related Experiment Videos
Oligonucleotide analogs as antiviral agents
Martin M Fabani1, John J Turner, Michael J Gait
1Medical Research Council, Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK.
Current Opinion in Molecular Therapeutics
|April 14, 2006
Summary
Oligonucleotide analogs show promise as antiviral agents. They work through various mechanisms, including direct viral RNA targeting and immune system stimulation.
Area of Science:
- Biochemistry
- Virology
- Immunology
Background:
- Oligonucleotide analogs are increasingly available.
- These compounds have potential as antiviral therapies.
Purpose of the Study:
- To explore the antiviral applications of oligonucleotide analogs.
- To detail the diverse mechanisms of action for these agents.
Main Methods:
- Review of existing literature on oligonucleotide analogs and their antiviral properties.
- Categorization of identified antiviral mechanisms.
Main Results:
- Oligonucleotide analogs can target viral RNAs via RNase H-mediated and steric block antisense strategies.
- Small interfering RNA (siRNA) is another RNA-targeting approach.
- Other mechanisms include blocking virus entry and stimulating Toll-like receptor 9 (TLR9) with CpG oligonucleotides.
Conclusions:
- A broad spectrum of oligonucleotide analogs offers versatile antiviral strategies.
- These strategies range from direct viral interference to host immune modulation.